October in review: Boots sold for US$8.9B, Omnibus VI approved, luxury beauty branches out
In October, Wittington Investments agreed to acquire Boots for US$8.9 billion. The European Parliament approved Omnibus VI, giving cosmetics makers more time to withdraw products containing carcinogenic, mutagenic, or reprotoxic (CMR) substances. Luxury beauty players pushed beyond their core categories as Puig posted record third-quarter revenue and Chanel sold its majority stake in Capsum. Global beauty companies also shifted from selling into India to building there, with investments spanning the value chain.This Technical Paper is brought to you by Ashland.
David Gordon, co-founder and CEO at EvanHealy, talks to us about building a botanical skin care brand in an increasingly crowded market. He explains how EvanHealy’s approach to ethical sourcing centers on personal relationships with farmers and producers, trust, and working with people who have a deep understanding of the land. We also explore the impact of climate change on botanical skin care and why direct engagement with farms is becoming increasingly important to ensure an ethical relationship with botanical sourcing.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines

Next-level “skinification” Oct 2026

Sustainable beauty solutionsSep 2026
Multimedia
David Gordon, co-founder and CEO at EvanHealy, talks to us about building a botanical skin care brand in an increasingly crowded market. He explains how EvanHealy’s approach to ethical sourcing centers on personal relationships with farmers and producers, trust, and working with people who have...






























